Tyrus Capital S.A.M. has filed its 13F form on November 14, 2023 for Q3 2023 where it was disclosed a total value porftolio of $10.5 Billion distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Atea Pharmaceuticals, Inc. with a value of $3.78B, Global Partner Acquisition Corp Ii with a value of $2.16B, Dhc Acquisition Corp with a value of $1.57B, L Catterton Asia Acquisition with a value of $1.07B, and Forbion European Acquisition Corp. with a value of $548M.

Examining the 13F form we can see an decrease of $3.7B in the current position value, from $14.2B to 10.5B.

Tyrus Capital S.A.M. is based out at Monaco, O9

Below you can find more details about Tyrus Capital S.A.M. portfolio as well as his latest detailed transactions.

Portfolio value $10.5 Billion
Healthcare: $3.78 Billion
Financial Services: $2.72 Billion
ETFs: $7.11 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $10.5 Billion
  • Prior Value $14.2 Billion
  • Filing
  • Period Q3 2023
  • Filing Date November 14, 2023
  • Form Type 13F-HR
  • Activity in Q3 2023
  • New Purchases 4 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Tyrus Capital S.A.M. Portfolio

Follow Tyrus Capital S.A.M. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyrus Capital S.A.M., based on Form 13F filings with the SEC.

News

Stay updated on Tyrus Capital S.A.M. with notifications on news.